3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Radiomics
1
Prostatic Neoplasms
1
Pituitary Diseases
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Lung Diseases
1
Liver Cirrhosis
1
Hepatitis B
1
Head and Neck Neoplasms
1
Disease Progression
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Carboplatin
10
Paclitaxel
5
Nivolumab
4
Pemetrexed
3
Cisplatin
3
atezolizumab
2
apatinib
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Blood Specimen Collection
2
Bevacizumab
2
zimberelimab
1
toripalimab
1
spartalizumab
1
sitravatinib
1
sintilimab
1
sacituzumab govitecan
1
pembrolizumab
1
lorlatinib
1
cemiplimab
1
camrelizumab
1
Vital Signs
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Telescopes
1
Talc
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lung Diseases
×
Radiomics
×
Clear all
NCT03872362
2019-03-13
RMBPN
Maastricht University
Completed
800 enrolled